CXCL9 expression is also elevated in NAFLD patients and a mouse model of NASH, with the CXCL9 protein detected in hepatocytes and sinusoidal endothelium in areas infiltrated by inflammatory cells66,67. Here, CXCL9 is linked to metabolic dysfunction-associated steatotic liver disease.